12:03 PM EDT, 03/17/2026 (MT Newswires) -- Cue Biopharma ( CUE ) filed a registration statement Monday for a $300 million mixed-shelf offering.

The company said it plans to offer, from time to time, up to $300 million of its debt securities, shares, subscription rights, units, and warrants.

As part of this mixed-shelf, Cue Biopharma ( CUE ) said it plans to sell up to about $12.7 million of its common shares through its 2021 open market sale agreement with Jefferies.

Cue Biopharma ( CUE ) shares were down more than 5% around midday Tuesday.

Price: 0.29, Change: -0.02, Percent Change: -7.06